Pharmaceutical Spray Drying Market 2026-2031: Cdmos Drive Growth With Integrated Particle‐Engineering Services
Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Spray Drying - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets's offering.
The pharmaceutical spray drying market, valued at USD 2.36 billion in 2026, is poised for significant growth, reaching USD 3.32 billion by 2031 at a CAGR of 7.12%. This market is a vital enabler for modern drug development strategies that focus on improved solubility and rapid bioavailability. Regulations supporting advanced solid dispersions and contract development and manufacturing organizations' (CDMOs) shift towards integrated particle-engineering services are key growth drivers.
Equipment advances are driving the market forward with real-time analytics and automation, aiding biopharma innovators in accelerating development cycles for APIs, vaccines, and inhalable therapies. Sustainability goals, solvent-reduction mandates, and energy efficiency objectives favor adoption of closed-loop and fusion-dispersion systems, establishing pharmaceutical spray drying as a leading choice for cutting-edge therapeutics.
The report segments the Pharmaceutical Spray Drying Market by application, formulation type, spray dryer type, scale, and geography with forecasts provided in USD value.
Growing Demand for Enhanced Drug Solubility
Approximately 40% of pipeline molecules have low aqueous solubility, necessitating spray-dried amorphous solid dispersions to optimize therapeutic potential. This approach significantly reduces dissolution time and improves bioavailability. Advances in matrices and processing methods ensure strong demand for spray drying solutions.
Rising Outsourcing of Pharmaceutical Formulation Services
The role of specialized CDMOs is increasing as pharmaceutical companies seek to scale quickly without heavy capital investment. Collaborations, like those between Catalent and Sanofi Active Ingredient Solutions, exemplify this trend. Outsourcing reduces validation risk and supports growth in the pharmaceutical spray drying market.
High Initial Capital Investment and Operating Costs
Spray dryer installations involve significant costs, including HEPA filtration and cleanroom requirements, impacting operational budgets. Innovations such as BUCHI's S-300 are helping to offset these expenses partially. Smaller companies often turn to CDMOs to manage costs effectively.
Other Market Drivers and and Challenges:
- Expansion of Inhalable and Oral Thin-Film Therapies Increased Adoption of Continuous Processing Technologies Strict Validation and Compliance Demands
Segment Analysis
Excipient production, capturing 42.85% of revenue in 2025, is crucial for spray drying technology. Market applications, especially for bioavailability enhancement, are expected to advance at a 9.05% CAGR, emphasizing the importance of these innovations. Taste-masking, controlled-release, and encapsulation are significant niches, with strategic acquisitions like Roquette's purchase of IFF Pharma Solutions highlighting the pivotal role of excipient innovation.
Small-molecule APIs contributed to 47.10% of 2025 revenue, with the technology enabling rapid dissolution. Vaccines, particularly mRNA/LNP formats, are projected to grow at 9.62% CAGR, benefiting from spray-dried formulations that don't rely on cold chains. Biologics also find utility in spray drying, maintaining structural integrity while preserving stability.
Geography Analysis
North America leads with a 39.85% share in 2025, supported by strong CDMO capacity and favorable regulatory frameworks. Asia-Pacific is expected to grow at an 8.18% CAGR, driven by expansion in China, South Korea, and India. Europe continues to be a manufacturing hub, while the Middle East & Africa and South America develop into regional formulation centers due to supportive initiatives.
Key Topics Covered:
Introduction- Study Assumptions & Market Definition Scope of the Study
- Market Overview Market Drivers Market Restraints Regulatory Landscape Porter's Five Forces
- By Application By Formulation Type By Spray Dryer Type By Scale Geography
- Market Concentration Market Share Analysis Company Profiles
- White-Space & Unmet-Need Assessment
A selection of companies mentioned in this report includes, but is not limited to:
- GEA Group AG SPX FLOW Inc. Buchi Labortechnik AG ProCepT N.V. European SprayDry Technologies Shandong Tianli Energy Labplant UK New AVM Systech Advanced Drying Systems Lemar Drying Engineering Freund-Vector Corp. Glatt GmbH Fluid Air (Spraying Systems) Syntegon Technology Spray-Tek Inc. Coperion GmbH Carrier Vibrating Equipment Powder Systems Ltd. Innojet GmbH Cyclops Spray Drying
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment